Evidence map›Paper›PMID 28292630›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

A plate method for rapid screening of Ketogulonicigenium vulgare mutants for enhanced 2-keto-l-gulonic acid production.

Weichao Yang, Litao Han, Mandlaa Mandlaa, Haihong Zhang, Zhongze Zhang, Hui Xu

Abstract readEvaluation Study
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Extremophiles in Space Exploration.Indian journal of microbiology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. High Throughput Screening Platform for a FAD-Dependent L-Sorbose Dehydrogenase.Frontiers in bioengineering and biotechnology · 2020
    Article
  7. High-Throughput Screening of a 2-Keto-L-Gulonic Acid-ProducingFrontiers in bioengineering and biotechnology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weichao YangChinese Academy of Sciences, Institute of Applied Ecology, Shenyang, China.
Litao HanNortheast Pharmaceutical Group Co., Ltd., Fermentation & Biotechnology Laboratory, Shenyang, China.
Mandlaa MandlaaChinese Academy of Sciences, Institute of Applied Ecology, Shenyang, China.
Haihong ZhangNortheast Pharmaceutical Group Co., Ltd., Fermentation & Biotechnology Laboratory, Shenyang, China.
Zhongze ZhangChinese Academy of Sciences, Institute of Applied Ecology, Shenyang, China.
Hui XuChinese Academy of Sciences, Institute of Applied Ecology, Shenyang, China. Electronic address: hui.xu67@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new plate method was developed for rapid screening of Ketogulonicigenium vulgare mutants overproducing 2-keto-l-gulonic acid (2-KLG). The screening methodology took the advantage of the acidity caused by 2-KLG, which changes the color of bromothymol blue (pH indicator) from blue to yellow. Using the proposed method, a mutant, K. vulgare 65, was selected from 20,000 colonies produced by a strain subjected to spaceflight mutagenesis. When co-cultured with Bacillus megaterium 2980 in 20-L fermenters, K. vulgare 65 showed a high conversion rate (94.45%) of l-sorbose to 2-KLG. In contrast to the traditional screening method, this one significantly improved the frequency of obtaining positive mutants. The proposed plate screening method is cost-effective and easy to run and is thus useful for the isolation and screening of K. vulgare mutants overproducing 2-KLG.

Indexed as

Bacteriological TechniquesFermentationMutationRhodobacteraceaeSorboseSugar Acidsprovitamin CSorboseSugar Acids2-Keto-l-gulonic acidKetogulonicigenium vulgarepH indicatorRapid screeningSpaceflight mutation

Identifiers

PMID28292630
PMCPMC5498444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.